B&O for TLH Post-operative Pain and Nausea
Completed · Phase 4 · Has a placebo group
Conditions studied: Hysterectomy, Pain, Postoperative
In brief
A prospective, single-center, double-blind, randomized, placebo-controlled trial to assess the impact of immediate post-operative placement of a Belladonna and Opium (B\&O) rectal suppository on postoperative pain and nausea following laparoscopic and robot-assisted hysterectomy.
Key facts
- Study ID
- NCT03657407
- Run by
- Anna Reinert
- People needed
- 56
- Starts
- 2016-06-01
- Expected to finish
- 2017-05-31
- Last updated by the study team
- 2019-04-02
Who can join
Age: 18 and older, up to 75. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- between ages 18 and 75,
- undergoing level I total laparoscopic or robot-assisted hysterectomy with or without bilateral salpingo-oophorectomy, cystoscopy, lysis of adhesions, or surgical treatment of endometriosis
You may not qualify if…
- contraindications to the use of B\&O (i.e. glaucoma, severe hepatic or renal disease, bronchial asthma, history of narcotic idiosyncracies, respiratory depression, convulsive disorders, acute alcoholism or delirium tremens, or regular use of an anticholinergic medication (twice per week or more frequently)
- additional surgical procedures being performed
Where it is running
- Mercy Medical Center — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.